The effect of implementing a guideline-based approach to achieve target LDL-C levels in very high risk patients. The PENELOPE study one year follow-up results.

28 August 2023 (10:15 - 11:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Sander Van Der Brug

Amphia Hospital, Breda (Netherlands (The))

8 More presentations in this session

Presentation thumbnail

Real world prognostic impact and predictors of adherence to statin therapy after STEMI on first year follow up: results from the FAST STEMI registry

Doctor L. Carmagnola (Turin, IT)

Abstract Slides Video

Presentation thumbnail

Long-term aspirin adherence and risk of cardiovascular events and death after myocardial infarction: A nationwide cohort study

Doctor A. Kristensen (Frederiksberg, DK)

Abstract Slides Video

Presentation thumbnail

A global perspective on cardiovascular risk factor management in patients with CHD and different educational level: SURF CHD II

Ms A. Marza Florensa (Utrecht, NL)

Abstract Slides Video

Presentation thumbnail

Lower income is associated with non-persistence to statin treatment after a first myocardial infarction

Mr K. Ma (Stockholm, SE)

Abstract Slides Video

Presentation thumbnail

Lipid assessment and achievement of secondary prevention european society of cardiology guideline targets in patients with atherosclerotic cardiovascular disease with and without depression

Doctor R. Summers (Swansea, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Secondary prevention

The Event

Event poster

ESC Congress 2023

28 August 2023 10:15 CET

You may be interested in

Congress Presentation

Comparing protocol-led lipid management with daily practice in post-myocardial infarction patients

Congress Session

Registries, observational, and other studies on lipids

Congress Session

What's new in lipid lowering?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources